Epigenetic markers of early tumor development

Methods in Molecular Biology

Volumn 863, Issue , 2012, Pages 3-14

  Dumitrescu, Ramona G ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Colorectal cancer; DNA hypermethylation; Folate; Global methylation; Lung cancer; Prostate cancer; Xenoestrogens

Indexed keywords

ESTRADIOL DERIVATIVE; FOLIC ACID; TUMOR MARKER;

ARTICLE; DNA METHYLATION; DRUG EFFECT; EARLY DIAGNOSIS; GENETIC EPIGENESIS; GENETICS; HUMAN; METHODOLOGY; NEOPLASM;

DNA METHYLATION; EARLY DETECTION OF CANCER; EPIGENESIS, GENETIC; ESTRADIOL CONGENERS; FOLIC ACID; HUMANS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84859971624     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-612-8_1     Document Type: Article

References (60)

1. Chung, W., Kwabi-Addo, B., Ittmann, M., Jelinek, J., Shen, L., Yu, Y., and Issa, J. P. (2008) Identifi cation of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profi ling. PLoS One 3, e2079.
2. Suzuki, M. and Yoshino, I. (2010) Aberrant methylation in non-small cell lung cancer. Surg Today 40, 602-607.
3. Hinshelwood, R. A. and Clark, S. J. (2008) Breast cancer epigenetics: Normal human mammary epithelial cells as a model system. J. Mol. Med. 86, 1315-1328.
4. Tlsty, T. D., Crawford, Y. G., Holst, C. R., Fordyce, C. A., Zhang, J., McDermott, K., Kozakiewicz, K., and Gauthier, M. L. (2004) Genetic and epigenetic changes in mammary epithelial cells may mimic early events in carcinogenesis. J Mammary Gland Biol Neoplasia 9, 263-274. (Pubitemid 39545743)
5. Holst, C. R., Nuovo, G. J., Esteller, M., Chew, K., Baylin, S. B., Herman, J. G., and Tlsty, T. D. (2003) Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res 63, 1596-1601. (Pubitemid 36373649)
6. Parrella, P., Poeta, M. L., Gallo, A. P., Prencipe, M., Scintu, M., Apicella, A., Rossiello, R., Liguoro, G., Seripa, D., et al. (2004) Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors. Clin. Cancer Res. 10, 5349-5354. (Pubitemid 39100470)
7. Silva, J., Silva, J. M., Dominguez, G., Garcia, J. M., Cantos, B., Rodriguez, R., Larrondo, F. J., Provencio, M., Espana, P., and Bonilla, F. (2003) Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms. J Pathol 199, 289-297. (Pubitemid 36266851)
8. Tlsty, T. D., Romanov, S. R., Kozakiewicz, B. K., Holst, C. R., Haupt, L. M., and Crawford, Y. G. (2001) Loss of chromosomal integrity in human mammary epithelial cells subsequent to escape from senescence. J Mammary Gland Biol Neoplasia 6, 235-243. (Pubitemid 33818526)
9. Romanov, S. R., Kozakiewicz, B. K., Holst, C. R., Stampfer, M. R., Haupt, L. M., and Tlsty, T. D. (2001) Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 409, 633-637. (Pubitemid 32154817)
10. Crawford, Y. G., Gauthier, M. L., Joubel, A., Mantei, K., Kozakiewicz, K., Afshari, C. A., and Tlsty, T. D. (2004) Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program. Cancer Cell 5, 263-273. (Pubitemid 38402118)
11. Reynolds, P. A., Sigaroudinia, M., Zardo, G., Wilson, M. B., Benton, G. M., Miller, C. J., Hong, C., Fridlyand, J., Costello, J. F., and Tlsty, T. D. (2006) Tumor suppressor p16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells. J Biol. Chem. 281, 24790-24802. (Pubitemid 44274253)
12. Dumitrescu, R. G. and Cotarla, I. (2005) Understanding breast cancer risk - where do we stand in 2005? J Cell Mol Med 9, 208-221.
13. Li, Y., Pan, J., Li, J. L., Lee, J. H., Tunkey, C., Saraf, K., Garbe, J. C., Whitley, M. Z., Jelinsky, S. A., et al. (2007) Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome senescence barriers and become immortalized. Mol Cancer 6, 7.
14. Berman, H., Zhang, J., Crawford, Y. G., Gauthier, M. L., Fordyce, C. A., McDermott, K. M., Sigaroudinia, M., Kozakiewicz, K., and Tlsty, T. D. (2005) Genetic and epigenetic changes in mammary epithelial cells identify a subpopulation of cells involved in early carcinogenesis. Cold Spring Harb Symp Quant Biol 70, 317-327. (Pubitemid 44124886)
15. Bean, G. R., Bryson, A. D., Pilie, P. G., Goldenberg, V., Baker, J. C., Jr., Ibarra, C., Brander, D. M., Paisie, C., Case, N. R., et al. (2007) Morphologically normal-Appearing mammary epithelial cells obtained from highrisk women exhibit methylation silencing of INK4a/ARF. Clin. Cancer Res. 13, 6834-6841. (Pubitemid 350206822)
16. Locke, I., Kote-Jarai, Z., Fackler, M. J., Bancroft, E., Osin, P., Nerurkar, A., Izatt, L., Pichert, G., Gui, G. P., and Eeles, R. A. (2007) Gene promoter hypermethylation in ductal lavage fl uid from healthy BRCA gene mutation carriers and mutation-negative controls. Breast Cancer Res 9, R20.
17. Vasilatos, S. N., Broadwater, G., Barry, W. T., Baker, J. C., Jr., Lem, S., Dietze, E. C., Bean, G. R., Bryson, A. D., Pilie, P. G., et al. (2009) CpG island tumor suppressor promoter methylation in non-BRCA-Associated early mammary carcinogenesis. Cancer Epidemiol. Biomarkers Prev. 18, 901-914.
18. Lewis, C. M., Cler, L. R., Bu, D. W., Zochbauer-Muller, S., Milchgrub, S., Naftalis, E. Z., Leitch, A. M., Minna, J. D., and Euhus, D. M. (2005) Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk. Clin. Cancer Res. 11, 166-172. (Pubitemid 40081117)
19. Euhus, D. M., Bu, D., Milchgrub, S., Xie, X. J., Bian, A., Leitch, A. M., and Lewis, C. M. (2008) DNA methylation in benign breast epithelium in relation to age and breast cancer risk. Cancer Epidemio. Biomarkers Prev 17, 1051-1059.
20. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., and Thun, M. J. (2007) Cancer statistics, 2007. CA Cancer J. Clin. 57, 43-66. (Pubitemid 46148091)
21. Belinsky, S. A. (2005) Silencing of genes by promoter hypermethylation: Key event in rodent and human lung cancer. Carcinogenesis 26, 1481-1487. (Pubitemid 41236040)
22. Belinsky, S. A., Palmisano, W. A., Gilliland, F. D., Crooks, L. A., Divine, K. K., Winters, S. A., Grimes, M. J., Harms, H. J., Tellez, C. S.m et al. (2002) Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Research 62, 2370-2377. (Pubitemid 34411720)
23. Belinsky, S. A., Nikula, K. J., Palmisano, W. A., Michels, R., Saccomanno, G., Gabrielson, E., Baylin, S. B., and Herman, J. G. (1998) Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc. Natl. Acad. Sci. U S A 95, 11891-11896.
24. Licchesi, J. D., Westra, W. H., Hooker, C. M., and Herman, J. G. (2008) Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung. Clin. Cancer Res. 14, 2570-2578.
25. Palmisano, W. A., Divine, K. K., Saccomanno, G., Gilliland, F. D., Baylin, S. B., Herman, J. G., and Belinsky, S. A. (2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60, 5954-5958.
26. Belinsky, S. A., Liechty, K. C., Gentry, F. D., Wolf, H. J., Rogers, J., Vu, K., Haney, J., Kennedy, T. C., Hirsch, F. R., et al. (2006) Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 66, 3338-3344.
27. Belinsky, S. A. (2004) Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 4, 707-717. (Pubitemid 39215069)
28. Shen, H., Spitz, M. R., Qiao, Y., Guo, Z., Wang, L. E., Bosken, C. H., Amos, C. I., and Wei, Q. (2003) Smoking, DNA repair capacity and risk of nonsmall cell lung cancer. Int J Cancer 107, 84-88. (Pubitemid 37100089)
29. Leng, S., Stidley, C. A., Willink, R., Bernauer, A., Do, K., Picchi, M. A., Sheng, X., Frasco, M. A., van den, B. D., et al. (2008) Double-strand break damage and associated DNA repair genes predispose smokers to gene methylation. Cancer Res 68, 3049-3056. (Pubitemid 351556307)
30. Liu, F., Killian, J. K., Yang, M., Walker, R. L., Hong, J. A., Zhang, M., Davis, S., Zhang, Y., Hussain, M., et al. (2010) Epigenomic alterations and gene expression profi les in respiratory epithelia exposed to cigarette smoke condensate. Oncogene 29, 3650-3664.
31. Nelson, W. G., De Marzo, A. M., DeWeese, T. L., Lin, X., Brooks, J. D., Putzi, M. J., Nelson, C. P., Groopman, J. D., and Kensler, T. W. (2001) Preneoplastic prostate lesions: An opportunity for prostate cancer prevention. AnnN Y Acad Sci 952, 135-144. (Pubitemid 34060016)
32. Nelson, W. G., De Marzo, A. M., and DeWeese, T. L. (2001) The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention. Urology 57, 39-45.
33. Lin, X., Tascilar, M., Lee, W. H., Vles, W. J., Lee, B. H., Veeraswamy, R., Asgari, K., Freije, D., van, R. B., et al. (2001) GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am. J. Pathol. 159, 1815-1826. (Pubitemid 33062524)
34. Ahmed, H. (2010) Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples. Biomark Cancer 17-33.
35. Nakayama, M., Gonzalgo, M. L., Yegnasub ramanian, S., Lin, X., De Marzo, A. M., and Nelson, W. G. (2004) GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer. JCell Biochem 91, 540-552.
36. Aitchison, A., Warren, A., Neal, D., and Rabbitts, P. (2007) RASSF1A promoter methylation is frequently detected in both pre-malignant and non-malignant microdissected prostatic epithelial tissues. Prostate 67, 638-644. (Pubitemid 46685284)
37. Troyer, D. A., Lucia, M. S., de Bruine, A. P., Mendez-Meza, R., Baldewijns, M. M., Dunscomb, N., van, E. M., McAskill, T., Bierau, K., et al. (2009) Prostate cancer detected by methylated gene markers in histopathologically cancer-negative tissues from men with subsequent positive biopsies. Cancer Epidemiol. Biomarkers Prev. 18, 2717-2722.
38. Cho, N. Y., Kim, J. H., Moon, K. C., and Kang, G. H. (2009) Genomic hypomethylation and CpG island hypermethylation in prostatic intraepithelial neoplasm. Virchows Arch. 454, 17-23.
39. Kim, M. S., Lee, J., and Sidransky, D. (2010) DNA methylation markers in colorectal cancer. Cancer Metastasis Rev. 29, 181-206.
40. Orlando, F. A., Tan, D., Baltodano, J. D., Khoury, T., Gibbs, J. F., Hassid, V. J., Ahmed, B. H., and Alrawi, S. J. (2008) Aberrant crypt foci as precursors in colorectal cancer progression. J Surg. Oncol. 98, 207-213.
41. Greenspan, E. J., Cyr, J. L., Pleau, D. C., Levine, J., Rajan, T. V., Rosenberg, D. W., and Heinen, C. D. (2007) Microsatellite instability in aberrant crypt foci from patients without concurrent colon cancer. Carcinogenesis 28, 769-776. (Pubitemid 46523333)
42. Menigatti, M., Truninger, K., Gebbers, J. O., Marbet, U., Marra, G., and Schar, P. (2009) Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters. Oncogene 28, 899-909.
43. Wallace, K., Grau, M. V., Levine, A. J., Shen, L., Hamdan, R., Chen, X., Gui, J., Haile, R. W., Barry, E. L., et al. (2010) Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa. Cancer Prev. Res. (Phila) 3, 1552-1564.
44. Balaguer, F., Link, A., Lozano, J. J., Cuatrecasas, M., Nagasaka, T., Boland, C. R., and Goel, A. (2010) Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res 70, 6609-6618.
45. Weissman, I. L., Anderson, D. J., and Gage, F. (2001) Stem and progenitor cells: Origins, phenotypes, lineage commitments, and transdifferentiations. Annu. Rev. Cell Dev. Biol. 17, 387-403. (Pubitemid 33096181)
46. Cheng, A. S., Culhane, A. C., Chan, M. W., Venkataramu, C. R., Ehrich, M., Nasir, A., Rodriguez, B. A., Liu, J., Yan, P. S., et al. (2008) Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. Cancer Res 68, 1786-1796. (Pubitemid 351416564)
47. Hsu, P. Y., Deatherage, D. E., Rodriguez, B. A., Liyanarachchi, S., Weng, Y. I., Zuo, T., Liu, J., Cheng, A. S., and Huang, T. H. (2009) Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. Cancer Res 69, 5936-5945.
48. Prins, G. S., Tang, W. Y., Belmonte, J., and Ho, S. M. (2008) Perinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesis. Basic. Clin. Pharmacol. Toxicol. 102, 134-138. (Pubitemid 351143423)
49. Jennings, E. (1995) Folic acid as a cancerpreventing agent. Med Hypotheses 45, 297-303.
50. Ciappio, E. and Mason, J.B. (2009) Folate and carcinogenesis: Mechanisms. In: Folate in Health and Disease (Bailey L & Taylor and Francis LLC eds.).
51. Xu, X. and Chen, J. (2009) One-carbon metabolism and breast cancer: An epidemiological perspective. J Genet Genomics 36, 203-214.
52. Miller, J. W., Borowsky, A. D., Marple, T. C., McGoldrick, E. T., llard-Telm, L., Young, L. J., and Green, R. (2008) Folate, DNA methylation, and mouse models of breast tumorigenesis. Nutr Rev 66 Suppl 1, S59-S64.
53. Ericson, U., Sonestedt, E., Ivarsson, M. I., Gullberg, B., Carlson, J., Olsson, H. and Wirfalt, E. (2009) Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmo Diet and Cancer cohort. Cancer Epidemiol. Biomarkers Prev. 18, 1101-1110.
54. Kim, Y. I. (2006) Does a high folate intake increase the risk of breast cancer? Nutr Rev 64, 468-475.
55. Larsson, S. C., Giovannucci, E., and Wolk, A. (2007) Folate and risk of breast cancer: A metaanalysis. J Natl Cancer Inst 99, 64-76.
56. Lewis, S. J., Harbord, R. M., Harris, R., and Smith, G. D. (2006) Meta-Analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk. J Natl. Cancer Inst. 98, 1607-1622. (Pubitemid 44811644)
57. Ma, E., Iwasaki, M., Junko, I., Hamada, G. S., Nishimoto, I. N., Carvalho, S. M., Motola, J., Jr., Laginha, F. M., and Tsugane, S. (2009) Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: A case-control study in Brazilian women. BMC Cancer 9, 122.
58. Mahoney, M. C., Bevers, T., Linos, E., and Willett, W. C. (2008) Opportunities and strategies for breast cancer prevention through risk reduction. CA Cancer J. Clin. 58, 347-371.
59. van, E. M., Weijenberg, M. P., Roemen, G. M., Brink, M., de Bruine, A. P., Goldbohm, R. A., van den Brandt, P. A., Baylin, S. B., De Goeij, A. F., and Herman, J. G. (2003) Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: The Netherlands cohort study on diet and cancer. Cancer Res. 63, 3133-3137. (Pubitemid 36735864)
60. Stidley, C. A., Picchi, M. A., Leng, S., Willink, R., Crowell, R. E., Flores, K. G., Kang, H., Byers, T., Gilliland, F. D., and Belinsky, S. A. (2010) Multivitamins, folate, and green vegetables protect against gene promoter methylation in the aerodigestive tract of smokers. Cancer Res. 70, 568-574.